AG-1295
CAS No. 71897-07-9
AG-1295( NSC 380341 | Tyrphostin AG 1295 )
Catalog No. M15750 CAS No. 71897-07-9
A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 72 | Get Quote |
|
| 25MG | 131 | Get Quote |
|
| 50MG | 222 | Get Quote |
|
| 100MG | 335 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAG-1295
-
NoteResearch use only, not for human use.
-
Brief DescriptionA quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.
-
DescriptionA quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM; inhibits PDGF-stimulated DNA synthesis with IC50 of 2.5 uM without affecting activity of EGFR; selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.Blood Cancer Discontinued.
-
In VitroCell Viability Assay Cell Line:Rabbit conjunctival fibroblasts cells Concentration:1 μM, 10 μM, 100 μM Incubation Time:3 days Result:Inhibited rabbit conjunctival fibroblast cell growth stimulated by PDGF-AA or PDGF-BB.
-
In VivoAnimal Model:Sprague-Dawley rats (240-270 g)Dosage:12 mg/kg Administration:Intraperitoneal injection; daily; for 14 or 21 days Result:Attenuated interstitial fibrosis in rat kidney after unilateral obstruction.
-
SynonymsNSC 380341 | Tyrphostin AG 1295
-
PathwayAngiogenesis
-
TargetPDGFR
-
RecptorPDGFR
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number71897-07-9
-
Formula Weight234.3
-
Molecular FormulaC16H14N2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (213.40 mM)
-
SMILESCC1=C(C)C=C2N=CC(C3=CC=CC=C3)=NC2=C1
-
Chemical Name6,7-dimethyl-2-phenyl-quinoxaline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kovalenko M, et al. Cancer Res. 1994 Dec 1;54(23):6106-14.
2. Banai S, et al. Circulation. 1998 May 19;97(19):1960-9.
3. Iwamoto H, et al. J Lab Clin Med. 2000 May;135(5):406-12.
4. Karck M, et al. Transplantation. 2002 Nov 15;74(9):1335-41.
molnova catalog
related products
-
CT52923
CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor.
-
PP58
PP58 is an inhibit of PDGFR, FGFR and Src family.
-
Toceranib
Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.
Cart
sales@molnova.com